Press "Enter" to skip to content

FDA authorizes Novavax’s updated COVID vaccine for fall 2023

The Food and Drug Administration announced Tuesday it had authorized Novavax’s updated COVID-19 vaccine, adding a third option for Americans ages 12 and older looking for a new shot this fall and winter.